Diabetes & Vascular Disease Research

Papers
(The median citation count of Diabetes & Vascular Disease Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target143
Progression of insulin resistance in individuals with type 1 diabetes: A retrospective longitudinal study on individuals from Thailand38
Longitudinal profiling and tracking stability in the Singapore study of macro-angiopathy and microvascular reactivity in type 2 diabetes cohort36
The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes29
MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism23
RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management18
Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis18
Disruption of COMMD1 accelerates diabetic atherosclerosis by promoting glycolysis13
Predictive value of lncRNA DBH-AS1 for cardiovascular events in patients with type 2 diabetes mellitus with coronary heart disease12
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment12
Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study11
High serum Bhlhe40 levels are associated with subclinical atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional study11
Alteration of autophagy-related protein 5 (ATG5) levels and Atg5 gene expression in diabetes mellitus with and without complications11
Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study10
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies10
“Arterial stiffness is not associated with changes in the circadian pattern of blood pressure in patients with type 1 diabetes mellitus and cardiovascular autonomic dysfunction”10
Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation10
Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999–20189
TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study9
Ten-year incidence of post-transplant Diabetes Mellitus in renal transplant patients9
Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes9
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review9
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease8
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study8
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis8
Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial8
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study8
Epicardial adipose tissue and right ventricular function in type 2 diabetes mellitus using two-dimensional speckle tracking echocardiography8
Function outperforms morphology in the assessment of muscular contribution to insulin sensitivity in premenopausal women7
Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with ty7
Aspirin use in patients with diagnosed diabetes in the United States and China: Nationally representative analysis7
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis6
A cross-sectional study exploring the relationship between oxidative balance score and 10-year atherosclerotic cardiovascular disease risk based on the National Health and Nutrition Examination Survey6
miR-1187 induces podocyte injury and diabetic nephropathy through autophagy6
Ultra-high frequency ultrasound delineated changes in carotid and muscular artery intima-media and adventitia thickness in obese early middle-aged women6
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study6
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study6
Responses of retinal and brain microvasculature to streptozotocin induced diabetes revealed by global expression profiling6
Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study6
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort study6
Diabetes mellitus is associated with an increased incidence of aortic valve stenosis6
Predictors of coronary artery calcium burden in asymptomatic patients with newly diagnosed type 2 diabetes mellitus5
Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists5
Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention5
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study4
Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 20194
Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort4
Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome4
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice4
The influence of cardiac rehabilitation on heart rate variability indices in men with type 2 diabetes and coronary artery disease4
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes4
Associations of prognostic nutritional index with risk of all-cause and cardiovascular disease mortalities in persons with gestational diabetes mellitus: A NHANES-based analysis3
The impact of semaglutide on wound healing in diabetes related foot ulcer patients: A TriNetX database study3
Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis3
Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial3
Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake3
Prevalence and risk factors of retinal vein occlusion in individuals with diabetes: The kailuan eye study3
Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis3
Impaired subendocardial perfusion in patients with metabolic syndrome3
Impact of COVID-19 therapy on hyperglycemia3
Cardiovascular risk factors, exercise capacity and health literacy in patients with chronic ischaemic heart disease and type 2 diabetes mellitus in Germany: Baseline characteristics of the Lifestyle I3
Impact of blood glucose control on clinical outcomes in type 2 diabetes patients hospitalized with COVID-19 infection3
Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques3
0.039169073104858